Category: Drug shortages

According to a September 2025 report from the American Society of Health-System Pharmacists (ASHP), several manufacturers of acetazolamide injection have reported shortages. The question, **"Is acetazolamide out of stock?"** has therefore become a pressing concern for patients and healthcare providers relying on this medication for conditions like glaucoma, altitude sickness, and heart failure. This article provides a comprehensive overview of the current supply issues, including which formulations are affected and what alternatives might be available.

In 2022, an estimated 9.3 million adults in the U.S. needed treatment for opioid use disorder (OUD), yet only a fraction received it [1.8.2]. This makes the current supply crisis critical, leading patients and providers to ask: **why is buprenorphine on backorder?** [1.2.2, 1.8.2]

According to the American Society of Health-System Pharmacists (ASHP), several manufacturers of dorzolamide ophthalmic solution have recently experienced supply issues, leading many to ask: **Is there a dorzolamide shortage?**.

According to the American Society of Health-System Pharmacists (ASHP), the US faced over 300 active drug shortages at the end of 2023, the highest number since recordkeeping began. For many patients starting their weight loss journey, a common concern is the availability of their medication, leading to the question: **is Zepbound 7.5 hard to get?** While supply issues previously affected certain doses, the national shortage for Zepbound was officially resolved by the FDA in late 2024, though localized issues and high demand can still present challenges.